Secondary adrenal insufficiency epidemiology and demographics: Difference between revisions

	Secondary adrenal insufficiency Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Adrenal insufficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Secondary adrenal insufficiency epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Secondary adrenal insufficiency epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Secondary adrenal insufficiency epidemiology and demographics
CDC on Secondary adrenal insufficiency epidemiology and demographics
Secondary adrenal insufficiency epidemiology and demographics in the news
Blogs on Secondary adrenal insufficiency epidemiology and demographics
Directions to Hospitals Treating Adrenal insufficiency
Risk calculators and risk factors for Secondary adrenal insufficiency epidemiology and demographics

VisualWikitext

Latest revision as of 21:21, 15 November 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

Overview

The prevalence of secondary adrenal insufficiency is approximately 15-28 per 100,000 individuals worldwide more common than Addison disease. The incidence increases with age; the median age at diagnosis is 60 years. There is no racial predilection. Women are more commonly affected by secondary adrenal insufficiency than male.

Epidemiology and Demographics

Prevalence

The prevalence of secondary adrenal insufficiency is approximately 15-28 per 100,000 individuals worldwide more common than Addison disease.^[1]

Age

The incidence of secondary adrenal insufficiency increases with age; the median age at diagnosis is 60 years.

Race

There is no racial predilection to secondary adrenal insufficiency.

Gender

Women are more commonly affected by secondary adrenal insufficiency than male.

References

↑ "www.nadf.us" (PDF).

Template:WH Template:WS

[urlwww.nadf.us-1] "www.nadf.us" (PDF).

[1]

@@ Line 1: / Line 1: @@
 __NOTOC__
-{{Adrenal insufficiency}}
+{{Secondary adrenal insufficiency}}
-{{CMG}}
+{{CMG}} {{AE}} {{ADS}}
 ==Overview==
+The [[prevalence]] of secondary adrenal insufficiency is approximately 15-28 per 100,000 individuals worldwide more common than [[Addison disease]]. The [[incidence]] increases with age; the median age at diagnosis is 60 years. There is no racial predilection. Women are more commonly affected by secondary adrenal insufficiency than male.
 ==Epidemiology and Demographics==
-In the United States, the prevalence of Addison’s disease per 1 million population is around 40-60 cases. Internationally, the occurrence of adrenal insufficiency is rare. In countries were epidemiological data is collected, the prevalence changes to 39 cases per 1 million population in the UK, 60 cases per 1 million population in Denmark. In Iceland, a study was conducted by Olafsson and Sigurjonsdottir that found a higher prevalence in this region, around 22.1 per 100,000 population. [10]
+===Prevalence===
+*The [[prevalence]] of secondary adrenal insufficiency is approximately 15-28 per 100,000 individuals worldwide more common than [[Addison disease]].<ref name="urlwww.nadf.us">{{cite web |url=http://www.nadf.us/tools/Braithwaite/Chrousos_2014_Lancet_Adrenal_Insufficiency.pdf |title=www.nadf.us |format= |work= |accessdate=}}</ref>
-Morbidity and mortality associated with Addison disease are usually due to an inability to determine a diagnosis or a delay in diagnosing a patient with adrenal insufficiency or a failure to provide the patient with the adequate hormonal replacement therapy they need i.e. glucorticoid and mineralocorticoid replacement. [11]
+===Age===
+*The [[incidence]] of secondary adrenal insufficiency increases with age; the median age at diagnosis is 60 years.
-Death may occur if acute addisonian crisis occurs without being promptly treated. This serious complication may occur as a new event (de novo) occurring in the presence of an adrenal hemorrhage or acutely on top of an inadequately treated adrenocortical insufficiency or a chronic case of insufficiency. With insidious chronic Addison disease debilitating symptoms may occur albeit low level and nonspecific. Despite diagnosis and adequate management, the risk of death in a patient with Addison disease is two times more likely, usually due to cardiovascular, malignant and infectious disease. [12]
+===Race===
+*There is no racial predilection to secondary adrenal insufficiency.
-The prevalence and risk factors for patients with Addison disease were analyzed using surveys by the authors White and Arlt. The following countries were included; United Kingdom, Canada, Australia, and New Zealand. The surveys found that about 8% of those that were diagnosed with Addison’s disease were hospitalized annually for adrenal crisis. Furthermore, the authors White and Arlt, found that patients suffering from Asthma, Diabetes Mellitus or had previously a GIT infection had an increased risk of getting Addison disease. [13][14] Moreover, a study by Chantzichristos et al indicated that patients who had type 1 or 2 diabetes, were likely to have higher mortality rates if they had Addison disease concomitantly over those that had diabetes alone. These same patients were followed up for almost 6 years and were found to have a mortality rate of 28% vs. 10% for those with diabetes and Addison vs. diabetes alone. Although it must be noted that cardiovascular deaths accounted for the highest mortality rate in both groups, nonetheless the relative overall mortality rate for one group over the other was estimated at 3.89. Other conditions such as diabetic complications, infectious disease and unknown causes along with Addison’s disease all tend to exacerbate the mortality rates versus diabetes alone. [15]
+===Gender===
+*Women are more commonly affected by secondary adrenal insufficiency than male.
-Race
-Addison disease has no specific predilection to any race.
-Sex
-Addison disease that is autoimmune in origin and tending to be idiopathic is more commonly found in females and children.
-Age
-Commonly, the age of presrntation is between 30-50 years of age., however, the disease may present itself earlier in association with other syndromes such as congenital adrenal hyperplasia, polyglandular syndromes or if the onset of Addison is secondary to a disorder of long chain fatty acid metabolism.
 ==References==
 {{Reflist|2}}
-[[Category:Needs content]]
 [[Category:Endocrinology]]
 [[Category:Disease]]